NCT06830850 2026-01-15A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate CancerAtridia Pty Ltd.Phase 1 Recruiting25 enrolled